These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5345907)

  • 21. Influence of dietary lipid on the metabolism of hexobarbital by the isolated, perfused rat liver.
    Lam TC; Wade AE
    Pharmacology; 1980; 21(1):64-7. PubMed ID: 7403257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of microsomal drug metabolism by 2-((2-(4-pyridyl)-methyl)-thio)-benzimidazole (H-718).
    Varga F; Fischer E; Szily T
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):227-34. PubMed ID: 4807135
    [No Abstract]   [Full Text] [Related]  

  • 23. Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes.
    Kato R; Gillette JR
    J Pharmacol Exp Ther; 1965 Nov; 150(2):285-91. PubMed ID: 4285416
    [No Abstract]   [Full Text] [Related]  

  • 24. Potent inhibitory action of pilocarpine on hepatic drug metabolism.
    Tsujimoto A; Doi T; Kojima S
    Jpn J Pharmacol; 1972 Oct; 22(5):736-9. PubMed ID: 4539795
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of anticholinesterase insecticides on hepatic microsomal metabolism.
    Stevens JT; Stitzel RE; McPhillips JJ
    J Pharmacol Exp Ther; 1972 Jun; 181(3):576-83. PubMed ID: 4624402
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of a pituitary mammotropic tumor on hepatic microsomal drug metabolism in the rat.
    Wilson JT
    Biochem Pharmacol; 1968 Jul; 17(7):1449-57. PubMed ID: 5690694
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship of dietary essential fatty acid consumption to hepatic drug hydroxylation.
    Wade AE; Wu B; Caster WO
    Pharmacology; 1972; 7(5):305-14. PubMed ID: 4644001
    [No Abstract]   [Full Text] [Related]  

  • 28. The inhibition of drug metabolism enzymes by some naturally occurring compounds.
    Graham PS; Hellyer RO; Ryan AJ
    Biochem Pharmacol; 1970 Mar; 19(3):759-68. PubMed ID: 5507683
    [No Abstract]   [Full Text] [Related]  

  • 29. EPR measurements of substrate interaction with cytochrome P-450.
    Cammer W; Schenkman JB; Estabrook RW
    Biochem Biophys Res Commun; 1966 May; 23(3):264-8. PubMed ID: 4289726
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of starvation and refeeding on the oxidation of drugs by liver microsomes.
    Kato R
    Biochem Pharmacol; 1967 May; 16(5):871-81. PubMed ID: 4382521
    [No Abstract]   [Full Text] [Related]  

  • 31. Concomitant association between high plasma levels of growth hormone and low hepatic mixed-function oxidase activity in the young rat.
    Wilson JT; Frohman LA
    J Pharmacol Exp Ther; 1974 Apr; 189(1):255-70. PubMed ID: 4362849
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of catecholamines upon the metabolism of foreign compounds and upon the distribution of perfusate in the isolated liver of the rat.
    Boobis AR; Powis G
    Biochem Pharmacol; 1974 Dec; 23(24):3377-84. PubMed ID: 4374219
    [No Abstract]   [Full Text] [Related]  

  • 33. Alteration of drug metabolism in rats and mice by an environment of cedarwood.
    Wade AE; Holl JE; Hilliard CC; Molton E; Greene FE
    Pharmacology; 1968 May; 1(5):317-28. PubMed ID: 4178661
    [No Abstract]   [Full Text] [Related]  

  • 34. Stress-induced alterations in microsomal drug metabolism in the adrenalectomized rat.
    Furner RL; Stitzel RE
    Biochem Pharmacol; 1968 Jan; 17(1):121-7. PubMed ID: 5638546
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):249-63. PubMed ID: 4372659
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of thiamine on the activity of the pyruvate dehydrogenase complex in rat liver following stimulation of lipogenesis].
    Parkhomenko IuM; Vovk AI; Protasova ZS; Chernysh IIu; Khalmuradov AG
    Ukr Biokhim Zh (1978); 1983; 55(4):408-14. PubMed ID: 6623667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further studies on the metabolism of drugs by subfractions of hepatic microsomes. 3. Effects of the NADPH-generating system.
    Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1967 Nov; 158(2):317-22. PubMed ID: 4383639
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of toxohormone on microsomal cytochromes and hydroxylating systems of rat liver.
    Takahashi A; Kato R
    J Biochem; 1969 Feb; 65(2):325-7. PubMed ID: 5771959
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of drug metabolism. 3. Further information of a new P-450 hemoprotein after treatment of rats with 3-methylcholanthrene.
    Shoeman DW; Chaplin MD; Mannering GJ
    Mol Pharmacol; 1969 Jul; 5(4):412-9. PubMed ID: 5803388
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction and inhibition of hepatic drug metabolizing enzymes by rifampin.
    Pessayre D; Mazel P
    Biochem Pharmacol; 1976 Apr; 25(8):943-9. PubMed ID: 1267838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.